|
| Register for our Free Newsletters |
|
 |
|
|
|
|
|
|
|
|
| Other Carouselweb publications |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
Sorin launches next-generation autotransfusion device in the USA
|
|
Sorin
: 04 May, 2011 (New Product) |
|
|
Sorin Group is launching in the USA the company’s next-generation of Sorin’s autotransfusion (ATS) device family, XTRA. |
|
|
An autotransfusion system is a piece of medical equipment that allows collection, processing and reinfusion of autologous blood during and after surgical interventions in many applications including cardiac, orthopaedic, vascular, obstetrics, trauma and others, as well as preoperative sequestration of whole blood components.
Sorin’s XTRA ATS System is the culmination of over 30 years of experience in ATS system design and manufacturing.
The XTRA builds on state-of-the-art technology, introducing innovative solutions through functional design, graphic colour operator’s interface and advanced data management. Building on the design of Sorin’s C5 and S5 world’s leading heart lung machines (HLM), the XTRA is an intuitive and powerful system, providing high quality end-product, fast processing and quietness during operation. A small volume disposable option also handles low blood volume loss typical in pediatrics and orthopedic cases.
Collecting and reinfusing autologous blood has gained renewed interest due to the increasing risks associated with donor blood transfusion. Blood recovered from a patient's own body reduces the risk of adverse reactions and infectious disease transmission, conserves blood supplies and provides cost savings.
“XTRA represents our most innovative and powerful system to date and is designed to meet the most demanding blood management programme requirements for ensuring Patient safety and improving surgical outcomes. We are looking forward to extensively offer the benefits of our new XTRA system to both patients and clinicians”, said Michel Darnaud, President, Cardiopulmonary Business Unit and Intercontinental, Sorin Group.
After an extensive market assessment study conducted in the USA and over four thousand clinical cases successfully conducted worldwide to date, the XTRA ATS System has been recently showcased in the USA at the American Society of ExtraCorporeal Technology (AmSECT) 49th International Conference, New Orleans, LA on April 13-16, 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
